NAS10029,403−1.38%S&P7,720−0.30%GOLD$3,978−1.32%BTC$77,995+0.28%VIX18.51+7.62%latest tape · as of 08:04 UTC
The Screen · Industrials · Building Products & Equipment
Armstrong World Industries, Inc.
AWI · the NYSE · USD · Market cap $7.2B · 4,000 employees
Armstrong World Industries, Inc., together with its subsidiaries, engages in the design, manufacture, and sale of ceiling and wall solutions in the Americas.
Positioning no disclosures inside 60 days, left as found
Options put/call open interest 2.04, read 2026-10-29
Ethical passes the values gate
Price165.95 USD
Fair value143.47
Ethical score70.0/100
Our investment reviews on this name
2026-10-11Read Accumulation162.68+2.0% to today ✓Markdown gives way to Accumulation
2026-09-24Read Markdown161.88+2.5% to today Markup gives way to Markdown after a 12% slide in 5 weeks
2026-08-22Read Markup183.97-9.8% to today Distribution gives way to Markup after a 19% rise in 7 weeks
2026-07-02Read Distribution154.21+7.6% to today First review on file: Distribution
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Armstrong World Industries, Inc. holds its Distribution at $165.95. The statistical read favours the sellers, held for 42 days.
As held on the ledger · 2026-10-29
Phase
Distribution · caution
Quantitative state
The statistical read favours the sellers, held for 42 days
Price at the screen
$165.95
Valuation
23.19 trailing · 17.70 forward price to earnings
Values screen
PASS· score 70.0
Beta
1.16
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
25.66%
Below 33%
Interest-bearing debt is just 25.7% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
12.64%
Below 49%
Money owed to the company is 12.6% of assets, under the 49% limit.
Pass
Revenue purity
0.15%
Below 5%
Only 0.1% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Clears, in Plain English
Armstrong World Industries, clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 26%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-10-29. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when AWI's ethical verdict changes
Today AWI passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
Fair value range in USD, drawn from the 2026-10-29 screen. The gold marker is the market price at the same screen. The price runs 13.5% above the base estimate.
Third-party analyst targets: 11 covering, consensus Buy. The average target sits +24% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-29 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Building products firm priced past its worth
Picture a contractor finishing an office fit-out and suddenly facing higher steel and labour costs that eat into every ceiling panel order. Armstrong World Industries sits right in that cycle, delivering 7% revenue growth, 19% profit margins and 36% return on equity, yet the shares trade 9% above our fair value with a forward multiple of 16.6 times.
Those numbers look respectable and the ethical screen clears without issue, but the opportunity rating stays at none because the business rides construction spending that peaks and troughs. When earnings sit near the top of the cycle, a mid-teens multiple often signals danger rather than value, and the gap to fair value only widens the concern.
Analyst targets sit higher at 204 dollars, yet history shows building-products earnings can fall sharply once projects slow. The combination of cyclical exposure and stretched valuation leaves little margin for error.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
AWI trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-10-27Accumulation$169.51+0.0%Entry 17
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 1%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (9 analysts) rates it buy, with a mean price target of $208. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-26Accumulation$169.51+0.0%Entry 16
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 1%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (9 analysts) rates it buy, with a mean price target of $208. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-25Accumulation$169.51+0.0%Entry 15
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 1%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (9 analysts) rates it buy, with a mean price target of $208. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-24Accumulation$169.51+0.0%Entry 14
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 1%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (9 analysts) rates it buy, with a mean price target of $208. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-23Accumulation$169.51+0.0%Entry 13
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 1%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (9 analysts) rates it buy, with a mean price target of $208. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-22Accumulation$169.51+0.0%Entry 12
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 1%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (9 analysts) rates it buy, with a mean price target of $208. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-21Accumulation$169.51+1.8%Entry 11
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 1.8% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 1%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (9 analysts) rates it buy, with a mean price target of $208. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-20Accumulation$166.59+0.0%Entry 10
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 1%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (9 analysts) rates it buy, with a mean price target of $208. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-18Accumulation$166.59+2.4%Entry 9
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 2.4% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 1%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (9 analysts) rates it buy, with a mean price target of $208.
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 1%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (9 analysts) rates it buy, with a mean price target of $208.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
